EPILEPSY (TREATMENT REFRACTORY)
Clinical trials for EPILEPSY (TREATMENT REFRACTORY) explained in plain language.
Never miss a new study
Get alerted when new EPILEPSY (TREATMENT REFRACTORY) trials appear
Sign up with your email to follow new studies for EPILEPSY (TREATMENT REFRACTORY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New brain device helps doctors tame Hard-to-Track seizures
Disease control Recruiting nowThis study follows 210 people with epilepsy who already have the Minder device implanted. The device helps doctors make better treatment decisions by detecting seizures that standard tests miss. Participants will be monitored every six months for two years to see how the device i…
Matched conditions: EPILEPSY (TREATMENT REFRACTORY)
Sponsor: Epiminder America, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Sound waves aimed at the brain could quiet seizures
Disease control Recruiting nowThis study tests whether low intensity focused ultrasound (LIFU) — sound waves delivered through a wearable headband — can reduce seizures in adults with drug-resistant epilepsy. Participants wear the device during treatment sessions, and researchers track seizure frequency and b…
Matched conditions: EPILEPSY (TREATMENT REFRACTORY)
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New scalp implant may unlock better epilepsy care for hard-to-diagnose patients
Knowledge-focused Recruiting nowThis study looks at whether a device called the Minder, implanted under the scalp, can help doctors make better treatment plans for people with epilepsy whose standard brain wave tests (EEG) are not clear. About 210 adults with drug-resistant epilepsy will either get the Minder d…
Matched conditions: EPILEPSY (TREATMENT REFRACTORY)
Phase: NA • Sponsor: Epiminder America, Inc. • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC